Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117445) titled 'Comparison of Anticoagulant Effects Between Nafamostat Mesylate and Sodium Citrate in Double Filtration Plasmapheresis' on Jan. 23.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital of Army Medical University PLA
Condition:
???????,???,ANCA??????,?????
Intervention:
Nafamostat mesilate:N/A
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-23
Target Sample Size: Nafamostat mesilate:70;Sodium citrate :70;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=298858
Discla...